NF-κB as a molecular target in adjuvant therapy of gastrointestinal carcinomas

European Journal of Surgical Oncology

Volumn 31, Issue 4, 2005, Pages 386-392

  Yu, Ying Yan ^a   Li, Q ^a   Zhu, Z G ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Gastrointestinal carcinoma; NF B; Therapeutic target

Indexed keywords

ACETYLSALICYLIC ACID; ANTISENSE OLIGONUCLEOTIDE; ARSENIC TRIOXIDE; BORTEZOMIB; CISPLATIN; CURCUMIN; CYTARABINE; DAUNORUBICIN; DISULFIRAM; DITHRANOL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLUTATHIONE; HALOPERIDOL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHAMPHETAMINE; PACLITAXEL; PHENOBARBITAL; PREDNISONE; SALAZOSULFAPYRIDINE; SPERGUALIN DERIVATIVE; SULINDAC; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CLINICAL TRIAL; DRUG TARGETING; GASTROINTESTINAL CARCINOMA; HUMAN; MEDICAL LITERATURE; MEDLINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM; ADJUVANT CHEMOTHERAPY; DRUG ANTAGONISM; GASTROINTESTINAL TUMOR; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GASTROINTESTINAL NEOPLASMS; HUMANS; NF-KAPPA B;

EID: 17144390219     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.10.010     Document Type: Review

References (73)

1. R. Sen D. Baltimore Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 46 1986 705-16
2. M. Karin A. Lin NF-kappaB at the crossroads of life and death Nat Immunol 3 3 2002 221-7
3. T.D. Gilmore Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel Oncogene 18 1999 6925-37
4. A.A. Habib S. Chatterjee S.K. Park R.R. Ratan S. Lefebvre T. Vartanian The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome J Biol Chem 276 12 2001 8865-74
5. F. Arenzana-Seisdedos P. Turpin M. Rodriguez D. Thomas R.T. Hay J.L. Virelizier et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm J Cell Sci 110 Pt 3 1997 369-78
6. S. Sachdev M. Hannink Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel Mol Cell Biol 18 9 1998 5445-56
7. B. Rayet C. Gelina Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 1999 6938-47
8. W. Wang J.L. Abbruzzese D.B. Evans L. Larry K.R. Cleary P.J. Chiao The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells Clin Cancer Res 5 1999 119-27
9. J. Suh A.B. Rabson NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem 91 2004 100-17
10. J.W. Lim H. Kim K.H. Kim Nuclear factor-κB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells Lab Invest 81 2001 349-60
11. N. Sasaki T. Morisaki K. Hashizume T. Yao M. Tsuneyoshi H. Noshiro et al. Nuclear factor-κB p65(Rel) transcription factor is constitutively activated in human gastric carcinoma tissue Clin Cancer Res 7 12 2001 4136-42
12. H. Nakshatri P. Bhat-Nakshatri D.A. Martin R.J. Goulet Jr G.W. Sledge Jr Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth Mol Cell Biol 17 1997 3629-39
13. A. Shibata T. Nagaya T. Imai H. Funahashi A. Nakao H. Seo Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells Breast Cancer Res Treat 73 2002 237-43
14. P. Bhat-Nakshatri C.J. Sweeney H. Nakshatri Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells Oncogene 21 2002 2066-78
15. J. Suh F. Payvandi L.C. Edelstein P.S. Amenta W.X. Zong C. Gelinas et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells Prostate 52 2002 183-200
16. N.M. Chandler J.J. Canete M.P. Callery Increased expression of NF-kappaB subunits in human pancreatic cancer cells J Surg Res 118 2004 9-14
17. M. Kojima T. Morisaki N. Sasaki K. Nakano R. Mibu M. Tanaka et al. Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression Anticancer Res 24 2B 2004 675-81
18. H.G. Yu L.L. Yu Y. Yang H.S. Luo J.P. Yu J.J. Meier Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis Oncology 65 1 2003 37-45
19. D.I. Tai S.L. Tsai Y.H. Chang S.N. Huang T.C. Chen K.S. Chang et al. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma Cancer 89 11 2000 2274-81
20. S. Huang J.B. Robinson A. Deguzman C.D. Bucana I.J. Fidler Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8 Cancer Res 60 19 2000 5334-9
21. G.F. Yang C.S. Deng Y.Y. Xiong L.L. Gong B.C. Wang J. Luo Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: Association with Helicobactor pylori cagA (+) infection World J Gastroenterol 10 4 2004 491-6
22. W. Wang H.S. Luo B.P. Yu Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions World J Gastroenterol 10 2 2004 177-81
23. Z.M. Liu G.G. Chen E.K. Ng W.K. Leung J.J. Sung S.C. Chung Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells Oncogene 23 2 2004 503-13
24. H.G. Yu X. Zhong Y.N. Yang H.S. Luo J.P. Yu J.J. Meier et al. Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer Int J Colorectal Dis 19 1 2004 18-22
25. M.P. Charalambous C. Maihofner U. Bhambra T. Lightfoot N.J. Gooderham Colorectal Cancer Study Group Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells Br J Cancer 88 10 2003 1598-604
26. M. Bentires-Alj V. Barbu M. Fillet A. Chariot B. Relic N. Jacobs et al. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells Oncogene 22 1 2003 90-7
27. S. Evertsson X.F. Sun Protein expression of NF-kappaB in human colorectal adenocarcinoma Int J Mol Med 10 5 2002 547-50
28. M. Kojima T. Morisaki K. Izuhara et al. Lipopolysaccharide increases cyclooxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation Oncogene 19 9 2000 1225-31
29. Y. Wang J. Dang H. Wang H. Allgayer G.A. Murrell D. Boyd Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor Eur J Biochem 267 11 2000 3248-54
30. J.C. Cusack Overcoming antiapoptotic responses to promote chemosensitivity in metastatic colorectal cancer to the liver Ann Surg Oncol 10 8 2003 852-62
31. C.-Y. Wang J.C. Cusack R. Liu A.S.J. Baldwin Control of inducible chemoresistance: Enhanced antitumor efficacy via increased apoptosis by inhibition of NF-κB Nat Med 5 4 1999 412-7
32. Y. Pommier O. Sordet S. Antony R.L. Hayward K.W. Kohn Apoptosis defects and chemotherapy resistance: Molecular interaction maps and networks Oncogene 23 16 2004 2934-49
33. Q. Shi X. Le B. Wang Q. Xiong J.L. Abbruzzese K. Xie Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells J Interferon Cytokine Res 20 11 2000 1023-8
34. W. Wang H.L. McLeod J. Cassidy Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines Int J Cancer 104 2003 504-11
35. S. Muerkoster A. Arlt M. Witt A. Gehrz S. Haye C. March et al. Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer Int J Cancer 104 4 2003 469-76
36. H. Yasui M. Adachi K. Imai Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo Ann N Y Acad Sci 1010 2003 273-7
37. H. Yasui M. Adachi K. Imai Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice Cancer 97 6 2003 1412-20
38. A. Garg B.B. Aggarwal Nuclear transcription factor-κB as a target for cancer drug development Leukemia 16 6 2002 1053-68
39. J.C. Cusack R. Liu M. Houston K. Abendroth P.J. Elliott J. Adams et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition Cancer Res 61 9 2001 3535-40
40. J.B. Sunwoo Z. Chen G. Dong N. Yeh C. Crowl Bancroft Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma Clin Cancer Res 7 5 2001 1419-28
41. J.C. Cusack Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib Cancer Treat Rev Suppl 1 2003 21-31
42. S. Meyer N.G. Kohler A. Joly Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation FEBS Lett 413 2 1997 354-8
43. P.J. Elliott T.M. Zollner W.H. Boehncke Proteasome inhibition: A new anti-inflammatory strategy J Mol Med 81 2003 235-45
44. N.M. Steffan G.D. Bren B. Frantz M.J. Tocci E.A. O'Neill C.V. Paya Regulation of IkB alpha phosphorylation by PKC-and Ca(2+)-dependent signal transduction pathways J Immunol 155 10 1995 4685-91
45. K. Katsuyama M. Shichiri F. Marumo Y. Hirata NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha Arterioscler Thromb Vasc Biol 18 11 1998 1796-802
46. Y.C. Lin K. Brown U. Siebenlist Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: Signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B Proc Natl Acad Sci USA 92 2 1995 552-6
47. G.M. Pieper Riaz-ul-Haq Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C J Cardiovasc Pharmacol 30 4 1997 528-32
48. S. Singh B.B. Aggarwal Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) J Biol Chem 270 42 1995 24995-5000
49. S. Cho Y. Urata T. Iida S. Goto M. Yamaguchi K. Sumikawa et al. Glutathione downregulates the phosphorylation of I kappa B: Autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells Biochem Biophys Res Commun 253 1 1998 104-8
50. T.R. Bakker D. Reed T. Renno C.V. Jongeneel Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis Int J Cancer 80 2 1999 320-3
51. W. Oitzinger R. Hofer-Warbinek J.A. Schmid Y. Koshelnick B.R. Binder et al. Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli Blood 97 6 2001 1611-7
52. F.R. Greten M. Karin The IKK/NF-kappaB activation pathway - a target for prevention and treatment of cancer Cancer Lett 206 2 2004 193-9
53. F. D'Acquisto A. Ialenti A. Ianaro R. Di Vaio R. Carnuccio Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw Gene Ther 7 20 2000 1731-7
54. S. Ono I. Date K. Onoda T. Shiota T. Ohmoto Y. Ninomiya et al. Decoy administration of NF-kappaB into the subarachnoid space for cerebral angiopathy Hum Gene Ther 9 7 1998 1003-11
55. H. Azuma N. Tomita Y. Kaneda H. Koike T. Ogihara Y. Katsuoka et al. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts Gene Ther 10 5 2003 415-25
56. M. Sumitomo M. Tachibana C. Ozu H. Asakura M. Murai M. Hayakawa et al. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression Hum Gene Ther 10 1 1999 37-47
57. M.W. Mayo A.S. Baldwin The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance Biochim Biophys Acta 1470 2000 M55-M62
58. C. Nakahara K. Nakamura N. Yamanaka E. Baba M. Wada H. Matsunaga et al. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells Clin Cancer Res 9 14 2003 5409-16
59. K. Beppu T. Morisaki H. Matsunaga A. Uchiyama E. Ihara K. Hirano Inhibition of interferon-γ-activated nuclear factor-kB by cyclosporine A: A possible mechanism for synergistic induction of apoptosis by interferon-γ and cyclosporine A in gastric carcinoma cells Biochem Biophys Res Commun 305 2003 797-805
60. H. Kim J.W. Lim J.Y. Seo K.H. Kim Oxidant-sensitive transcription factor and cyclooxygenase-2 by Helicobacter pylori stimulation in human gastric cancer cells J Environ Pathol Toxicol Oncol 21 2 2002 121-9
61. R.Z. Orlowski A.S. Baldwin Jr NF-kappaB as a therapeutic target in cancer Trends Mol Med 8 2002 385-9
62. B.B. Aggarwal A. Kumar A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 23 1A 2003 363-98
63. C. Aghajanian S. Soignet D.S. Dizon C.S. Pien J. Adams P.J. Elliott et al. A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies Clin Cancer Res 8 8 2002 2505-11
64. H. Uetsuka M. Haisa M. Kimura M. Gunduz Y. Kaneda T. Ohkawa et al. Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line Exp Cell Res 289 2003 27-35
65. C.Y. Liu Y.Y. Lai C.J. Lo Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells J Surg Res 117 2 2004 223-31
66. S.N. Hochwald D.S. Lind J. Malaty E.M. Copeland III L.L. Moldawer MacKay Antineoplastic therapy in colorectal cancer through proteasome inhibition Am Surg 69 1 2003 15-23
67. S.H. Jin T.I. Kim D.S. Han S.K. Shin W.H. Kim Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells Ann N Y Acad Sci 973 2002 414-8
68. W. Wang E. Collie-Duguid J. Cassidy Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines FEBS Lett 531 3 2002 415-20
69. D.S. Lind S.N. Hochwald J. Malaty S. Rekkas P. Hebig G. Mishra et al. Nuclear factor-kappa B is upregulated in colorectal cancer Surgery 130 2 2001 363-9
70. S.M. Plummer K.A. Holloway M.M. Manson R.J. Munks A. Kaptein S. Farrow et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex Oncogene 18 44 1999 6013-20
71. I. Kawamura R. Morishita N. Tomita E. Lacey M. Aketa S. Tsujimoto et al. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model Gene Ther 6 1 1999 91-7
72. B.C. Wong X. Jiang X.M. Fan M.C. Lin S.H. Jiang S.K. Lam et al. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer Oncogene 22 8 2003 1189-97
73. H.L. Li D.D. Chen X.H. Li H.W. Zhang Y.Q. Lu C.L. Ye et al. Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: Role of reactive oxygen species World J Gastroenterol 8 3 2002 431-5